Thank you to everyone who attended the inaugural Cannabis Europa in London. The speakers, sponsors and attendees who came from five continents truly made this the foremost arena to share knowledge and shape the future of medical cannabis in Europe.
Read MoreIndustry trends in Europe are heading towards a research-driven approach to cannabis and the further assertion of the drug as a medicine and a way to help people that are suffering. Kfir Kachlon, Senior Analyst and Cannabis-Tech Lead at OurCrowd writes on his experience at Cannabis Europa.
Read MoreCannabis Europa features talks and debates from the industry’s leading figureheads across business, regulation, science and health. With a range of incredible speakers and thought-provoking discussions, check out some of these top tips that will help you make the most of your experience at the Barbican.
Read MoreAlfie Dingley, Victoria Atkins, the Royal College of Nursing… More and more stories are making headlines relating to medical cannabis in the United Kingdom. They reflect both the growing interest in medical cannabis and what many view as its imminent regulation.
Read MoreSpeculation about the economic impact of legalisation is running rampant as medical cannabis markets open across the globe and Canada prepares for the introduction of a legal, commercial marketplace for recreational cannabis.
Read MoreThe UK is quickly falling behind it’s European neighbours in terms of medical cannabis access. However, a London conference, Cannabis Europa, is looking to change public opinion on the issue and engage with regulators, scientists and advocates.
Read MoreOne of the key challenges facing regulators and producers in implementing medical cannabis programmes in any jurisdiction is how to do so in a way that best promotes and protects public health.
Read MoreOne of the key challenges facing regulators and producers in implementing medical cannabis programmes in any jurisdiction is how to do so in a way that best promotes and protects public health.
Read MoreEuropean medical cannabis markets are not yet mature, and consumer trends are only beginning to emerge and product choice broadens. What can be learnt from the more mature markets that have been operating on the other side of the Atlantic?
Read More
